(Editor’s note re-printed from Homeland Security Newswire)

The state of public health and biodefense

Published 7 September 2009

There are two bookends to U.S. concern with bioterror attacks on the United States: the fall 2001 anthrax-by-mail attacks, and the December 2007 report by a blue-ribbon commission, headed by former senators Bob Graham of Florida and Jim Talent of Missouri, asserting that of all the weapons of mass destruction, terrorists would likely use biological weapons against the United States because these weapons are easier to produce and deliver than nuclear weapons, and much deadlier than chemical weapons.

The Bush administration did not wait for the commission’s report to allocate $5 billion to its BioShield project, which distributes money to companies engaged in research and development of vaccines and treatments to counter bioterror attacks.

The interest in food safety is a more recent phenomenon, reflecting growing worries about the side effects of globalization. More and more food items – and ingredients used in food items — are imported into the United States. Trouble is, many of the countries from which these items are imported have much lower health and safety standards than the United States does – and often, even if health and safety measures are on the books, endemic corruption in many of these countries guarantees that these standards are not enforced.

What exacerbated the problem was the Bush administration’s cuts in the budget of the Food and Drug Administration (FDA), making the agency’s already difficult inspection task nearly impossible. These two conflicting trends – steady increase in the importation of food and food ingredients into the United States, and steady decline since 2001 in the budget and inspection personnel of the FDA – combined to create an explosion of food recalls in 2007 and 2008, prompting Congress to consider much tougher food inspection regime, but also prompting the industry and individual companies to formulate their own tougher policies of health and safety standards.

Just as the growing awareness of bioterrorism has been beneficial to many biotechnology companies – especially start ups – so has the awareness of the need for more effective food safety regime. Thus, according to BCC research, the U.S. food safety testing market value increased from $2.0 billion in 2006 to about $2.1 billion in 2007, and it should reach $2.8 billion by 2012, a compound annual growth rate (CAGR) of 5.8 percent. The growth rate reflects demand for pathogen testing, where implementation of standard hygiene practices and a stringent regulatory environment has slowed the incidence of microbial infections.

The research form says that the potency of toxins should propel testing for contaminants from a $78 million market in 2007 to a $135 million market in 2012, a CAGR of 11.6 percent.

To opt in for AdVnt Biotechnologies product updates & notifications follow this link… http://eepurl.com/gYvBv